HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Eitemau Tebyg

• HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
  gan: Montoto, S, et al.
  Cyhoeddwyd: (2011)
• HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
  gan: Montoto, S, et al.
  Cyhoeddwyd: (2012)
• Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
  gan: Bhanu Vakkalanka, et al.
  Cyhoeddwyd: (2011-01-01)
• The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
  gan: Adam F. Binder, et al.
  Cyhoeddwyd: (2017-10-01)
• Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
  gan: Diego Villa, et al.
  Cyhoeddwyd: (2018-12-01)